Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Invested Capital (2016 - 2025)

Marimed (MRMD) has disclosed Invested Capital for 15 consecutive years, with $58.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Invested Capital fell 18.48% to $58.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $58.7 million, a 18.48% decrease, with the full-year FY2024 number at $62.5 million, down 14.7% from a year prior.
  • Invested Capital was $58.7 million for Q3 2025 at Marimed, down from $60.6 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $113.0 million in Q2 2023 to a low of $14.8 million in Q1 2021.
  • A 5-year average of $58.5 million and a median of $61.6 million in 2022 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: soared 20139.53% in 2021, then plummeted 36.69% in 2024.
  • Marimed's Invested Capital stood at $36.3 million in 2021, then skyrocketed by 69.5% to $61.6 million in 2022, then grew by 18.92% to $73.3 million in 2023, then fell by 14.7% to $62.5 million in 2024, then decreased by 6.04% to $58.7 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Invested Capital are $58.7 million (Q3 2025), $60.6 million (Q2 2025), and $61.7 million (Q1 2025).